Phreesia, Inc. (NYSE:PHR) CFO Sells $173,360.84 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 5,771 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $30.04, for a total value of $173,360.84. Following the completion of the transaction, the chief financial officer now owns 105,514 shares of the company’s stock, valued at $3,169,640.56. This represents a 5.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Balaji Gandhi also recently made the following trade(s):

• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total transaction of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total transaction of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Price Performance

PHR stock opened at $28.49 on Friday. The firm has a 50 day moving average of $27.22 and a 200-day moving average of $23.80. The firm has a market capitalization of $1.66 billion, a P/E ratio of -19.38 and a beta of 0.96. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same quarter in the previous year, the company posted ($0.58) earnings per share. The company’s revenue was up 16.6% compared to the same quarter last year. As a group, sell-side analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Citigroup increased their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Robert W. Baird dropped their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. KeyCorp upped their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Piper Sandler reissued an “overweight” rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Finally, Truist Financial upped their price objective on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Thirteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $31.15.

Institutional Trading of Phreesia

Hedge funds have recently added to or reduced their stakes in the business. Johnson Financial Group Inc. increased its stake in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd purchased a new stake in shares of Phreesia in the 4th quarter worth about $30,000. BankPlus Trust Department purchased a new position in shares of Phreesia during the 4th quarter worth approximately $34,000. International Assets Investment Management LLC grew its stake in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares during the period. Finally, Quarry LP lifted its position in Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after buying an additional 1,923 shares during the period. 92.10% of the stock is owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.